{"id":"https://openalex.org/W4361950450","doi":"https://doi.org/10.1158/1078-0432.c.6532649","title":"Data from Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2\u2212 ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study","display_name":"Data from Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2\u2212 ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361950450","doi":"https://doi.org/10.1158/1078-0432.c.6532649"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6532649","doi":"https://doi.org/10.1158/1078-0432.c.6532649","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532649","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6532649","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032987754","display_name":"Massimo Cristofanilli","orcid":"https://orcid.org/0000-0002-4194-7175","observed_orcids":["https://orcid.org/0000-0002-4194-7175"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Massimo Cristofanilli","raw_affiliation_strings":["Weill Cornell Medicine, New York, New York"],"raw_orcid":"https://orcid.org/0000-0002-4194-7175","affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090188675","display_name":"Hope S. Rugo","orcid":"https://orcid.org/0000-0001-6710-4814","observed_orcids":["https://orcid.org/0000-0001-6710-4814"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hope S. Rugo","raw_affiliation_strings":["University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069050806","display_name":"Seock\u2010Ah Im","orcid":"https://orcid.org/0000-0002-5396-6533","observed_orcids":["https://orcid.org/0000-0002-5396-6533"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Seock-Ah Im","raw_affiliation_strings":["Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of South Korea"],"raw_orcid":"https://orcid.org/0000-0002-5396-6533","affiliations":[{"raw_affiliation_string":"Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of South Korea","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":["David Geffen School of Medicine at University of California Los Angeles, Santa Monica, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at University of California Los Angeles, Santa Monica, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027231412","display_name":"Nadia Harbeck","orcid":"https://orcid.org/0000-0002-9744-7372","observed_orcids":["https://orcid.org/0000-0002-9744-7372"]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nadia Harbeck","raw_affiliation_strings":["Brustzentrum, Frauenklinik and CCC Munich, LMU University Hos-pital, Munich, Germany"],"raw_orcid":"https://orcid.org/0000-0002-9744-7372","affiliations":[{"raw_affiliation_string":"Brustzentrum, Frauenklinik and CCC Munich, LMU University Hos-pital, Munich, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019547742","display_name":"Igor Bondarenko","orcid":"https://orcid.org/0000-0002-7071-2471","observed_orcids":["https://orcid.org/0000-0002-7071-2471"]},"institutions":[{"id":"https://openalex.org/I905458539","display_name":"Dnipro State Medical University","ror":"https://ror.org/0469ncz24","country_code":"UA","type":"healthcare","lineage":["https://openalex.org/I905458539"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Igor Bondarenko","raw_affiliation_strings":["Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine"],"raw_orcid":"https://orcid.org/0000-0002-7071-2471","affiliations":[{"raw_affiliation_string":"Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine","institution_ids":["https://openalex.org/I905458539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067189124","display_name":"Norikazu Masuda","orcid":"https://orcid.org/0000-0002-7302-0278","observed_orcids":["https://orcid.org/0000-0002-7302-0278"]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norikazu Masuda","raw_affiliation_strings":["Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan"],"raw_orcid":"https://orcid.org/0000-0002-7302-0278","affiliations":[{"raw_affiliation_string":"Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053376791","display_name":"Marco Angelo Colleoni","orcid":"https://orcid.org/0000-0002-5743-3013","observed_orcids":["https://orcid.org/0000-0002-5743-3013","https://orcid.org/0000-0003-1925-2139"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Colleoni","raw_affiliation_strings":["IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy"],"raw_orcid":"https://orcid.org/0000-0002-5743-3013","affiliations":[{"raw_affiliation_string":"IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537242","display_name":"Angela M. DeMichele","orcid":"https://orcid.org/0000-0003-1297-4251","observed_orcids":["https://orcid.org/0000-0003-1297-4251"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela DeMichele","raw_affiliation_strings":["Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010278367","display_name":"Sherene Loi","orcid":"https://orcid.org/0000-0001-6137-9171","observed_orcids":["https://orcid.org/0000-0001-6137-9171"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Sherene Loi","raw_affiliation_strings":["Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia"],"raw_orcid":"https://orcid.org/0000-0001-6137-9171","affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008549101","display_name":"Hiroji Iwata","orcid":"https://orcid.org/0000-0002-0242-4718","observed_orcids":["https://orcid.org/0000-0002-0242-4718"]},"institutions":[{"id":"https://openalex.org/I4405286927","display_name":"Aichi Cancer Center Hospital","ror":"https://ror.org/03kh0z432","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroji Iwata","raw_affiliation_strings":["Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0242-4718","affiliations":[{"raw_affiliation_string":"Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan","institution_ids":["https://openalex.org/I4405286927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027068050","display_name":"Ben O\u2019Leary","orcid":"https://orcid.org/0000-0002-1092-9169","observed_orcids":["https://orcid.org/0000-0002-1092-9169"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ben O'Leary","raw_affiliation_strings":["Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-1092-9169","affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001814176","display_name":"Fabrice Andr\u00e9","orcid":"https://orcid.org/0000-0001-5795-8357","observed_orcids":["https://orcid.org/0000-0001-5795-8357","https://orcid.org/0000-0002-6272-6048"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabrice Andr\u00e9","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":"https://orcid.org/0000-0001-5795-8357","affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087559224","display_name":"Sibylle Loibl","orcid":"https://orcid.org/0000-0001-6488-4958","observed_orcids":["https://orcid.org/0000-0001-6488-4958"]},"institutions":[{"id":"https://openalex.org/I4210130803","display_name":"German Breast Group","ror":"https://ror.org/03c8hnh70","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4210130803"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sibylle Loibl","raw_affiliation_strings":["German Breast Group, Neu-Isenburg, Germany"],"raw_orcid":"https://orcid.org/0000-0001-6488-4958","affiliations":[{"raw_affiliation_string":"German Breast Group, Neu-Isenburg, Germany","institution_ids":["https://openalex.org/I4210130803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090337589","display_name":"Eustratios Bananis","orcid":"https://orcid.org/0000-0001-6553-7114","observed_orcids":["https://orcid.org/0000-0001-6553-7114"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eustratios Bananis","raw_affiliation_strings":["Pfizer Inc, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100390862","display_name":"Yuan Liu","orcid":"https://orcid.org/0000-0002-2728-5718","observed_orcids":["https://orcid.org/0000-0002-2728-5718"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuan Liu","raw_affiliation_strings":["Pfizer Inc, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075134210","display_name":"Xin Huang","orcid":"https://orcid.org/0000-0003-3285-365X","observed_orcids":["https://orcid.org/0000-0003-3285-365X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Huang","raw_affiliation_strings":["Pfizer Inc, San Diego, California"],"raw_orcid":"https://orcid.org/0000-0003-3285-365X","affiliations":[{"raw_affiliation_string":"Pfizer Inc, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010886287","display_name":"Sindy Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sindy Kim","raw_affiliation_strings":["Pfizer Inc, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072901381","display_name":"Maria Jose Lechuga Frean","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Jose Lechuga Frean","raw_affiliation_strings":["Pfizer Inc, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, San Diego, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060044961","display_name":"Nicholas C. Turner","orcid":"https://orcid.org/0000-0001-8937-0873","observed_orcids":["https://orcid.org/0000-0001-8937-0873"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas C. Turner","raw_affiliation_strings":["Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":21,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9810000061988831},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":1.0},{"id":"https://openalex.org/keywords/hr-her2-advanced-breast-cancer","display_name":"HR+/HER2- advanced breast cancer","score":0.9570000171661377},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8960000276565552},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.8759999871253967},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8880000114440918},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.6639999747276306},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.8009999990463257},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.9549999833106995},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.5899999737739563},{"id":"https://openalex.org/keywords/paloma-3","display_name":"PALOMA-3","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9518394470214844},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.9276778697967529},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7129257917404175},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6071423888206482},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6046688556671143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6022018790245056},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4667019844055176},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.44524896144866943},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40582582354545593},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40071478486061096},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39125216007232666},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.36735206842422485},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.2632128596305847},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.19479167461395264},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6532649","doi":"https://doi.org/10.1158/1078-0432.c.6532649","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532649","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6532649.v1","doi":"https://doi.org/10.1158/1078-0432.c.6532649.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6532649.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6532649","doi":"https://doi.org/10.1158/1078-0432.c.6532649","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532649","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W2132826012","https://openalex.org/W2137620209","https://openalex.org/W2158679766","https://openalex.org/W2206697844","https://openalex.org/W2290950904","https://openalex.org/W2560561127","https://openalex.org/W2892043300","https://openalex.org/W2896846857","https://openalex.org/W2897693137","https://openalex.org/W2998166168","https://openalex.org/W3165841382","https://openalex.org/W3167855488","https://openalex.org/W3184794943","https://openalex.org/W3207556705","https://openalex.org/W4210430911"],"related_works":["https://openalex.org/W4280523559","https://openalex.org/W3166403155","https://openalex.org/W2898484591","https://openalex.org/W3089072588","https://openalex.org/W2896846857","https://openalex.org/W4248789801","https://openalex.org/W3165841382","https://openalex.org/W3013314701","https://openalex.org/W2901794956","https://openalex.org/W4411371090"],"abstract_inverted_index":{"AbstractPurpose:":[0],"To":[1],"conduct":[2],"an":[3],"updated":[4],"exploratory":[5],"analysis":[6,26,72,88],"of":[7,16,24,77,199,229,243],"overall":[8],"survival":[9],"(OS)":[10],"with":[11,36,167,172,184,220,226,233],"a":[12,241],"longer":[13],"median":[14,117],"follow-up":[15,230],"73.3":[17],"months":[18,125,133],"and":[19,33,61,68,105,112,131,155,161,192,197],"evaluate":[20],"the":[21,98,110,128,136,159],"prognostic":[22],"value":[23],"molecular":[25],"by":[27],"circulating":[28,194],"tumor":[29,195],"DNA":[30],"(ctDNA).":[31],"Patients":[32,35],"Methods:":[34],"hormone":[37],"receptor\u2013positive/human":[38],"epidermal":[39],"growth":[40],"factor":[41],"receptor":[42],"2\u2013negative":[43],"(HR+/HER2\u2212)":[44],"advanced":[45],"breast":[46],"cancer":[47],"(ABC)":[48],"were":[49,210],"randomized":[50,85],"2:1":[51],"to":[52],"receive":[53],"palbociclib":[54,111,129,160,168,221,237],"(125":[55],"mg":[56,64],"orally/day;":[57],"3/1":[58],"week":[59],"schedule)":[60],"fulvestrant":[62,170,175,223,239],"(500":[63],"intramuscularly)":[65],"or":[66,202],"placebo":[67,113,137,162,173],"fulvestrant.":[69],"This":[70],"OS":[71,118,148,166,218],"was":[73,89,123,152,176,224],"performed":[74,90],"when":[75],"75%":[76],"enrolled":[78],"patients":[79,92,183,232],"died":[80],"(393":[81],"events":[82],"in":[83,109,127,135,158,178,182,217,231,245],"521":[84],"patients).":[86],"ctDNA":[87],"among":[91],"who":[93],"provided":[94],"consent.":[95],"Results:":[96],"At":[97],"data":[99],"cutoff":[100],"(August":[101],"17,":[102],"2020),":[103],"258":[104],"135":[106],"deaths":[107],"occurred":[108],"groups,":[114,163],"respectively.":[115,164],"The":[116,146,213],"[95%":[119],"confidence":[120],"interval":[121],"(CI)]":[122],"34.8":[124],"(28.8\u201339.9)":[126],"group":[130,138],"28.0":[132],"(23.5\u201333.8)":[134],"(stratified":[139],"hazard":[140],"ratio,":[141],"0.81;":[142],"95%":[143],"CI,":[144],"0.65\u20130.99).":[145],"6-year":[147],"rate":[149],"(95%":[150],"CI)":[151],"19.1%":[153],"(14.9\u201323.7)":[154],"12.9%":[156],"(8.0\u201319.1)":[157],"Favorable":[165],"plus":[169,174,222,238],"compared":[171],"observed":[177],"most":[179],"subgroups,":[180],"particularly":[181],"endocrine-sensitive":[185],"disease,":[186],"no":[187],"prior":[188],"chemotherapy":[189],"for":[190],"ABC":[191],"low":[193],"fraction":[196],"regardless":[198],"ESR1,":[200],"PIK3CA,":[201],"TP53":[203],"mutation":[204],"status.":[205],"No":[206],"new":[207],"safety":[208],"signals":[209],"identified.":[211],"Conclusions:":[212],"clinically":[214],"meaningful":[215],"improvement":[216],"associated":[219],"maintained":[225],">6":[227],"years":[228],"HR+/HER2\u2212":[234],"ABC,":[235],"supporting":[236],"as":[240],"standard":[242],"care":[244],"these":[246],"patients.":[247]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}